A study by Altinove et al. in 2015 [88] observed no change in circulating Sel P levels in women with GDM; however, another study showed increased levels of SelP associated with the development of preeclampsia and suggested that SelP might be a suitable biomarker for the detection of preeclampsia, albeit in association with other determinants [89]. The gene discussed is SELP; the disease is preeclampsia.